approved EB-2 (NIW)

Scientific Project Manager

Cell Biology · India · 2024-12-02

Processing Time
26 days
Decision Date
2024-12-02
Location
Alabama
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner plans to develop precision biomarker oncology tests for biopsy samples to advance clinical cancer trials and drug development. Her work focuses on elucidating unique characteristics of cancer cells to establish therapeutic targets for precision medicine.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The endeavor addresses the national interest in reducing cancer mortality through the development of precision oncology tests.

2 Well-positioned to Advance the Endeavor Met

The petitioner's Ph.D. and record of 6 peer-reviewed publications with 99 citations demonstrate her ability to advance the field.

3 Waiver Benefit Met

On balance, the petitioner's specialized research in cancer biomarkers justifies waiving the job offer and labor certification requirements.

Why This Petition Was Approved

The petition was approved based on the petitioner's Ph.D. in Cellular and Developmental Biology and a record of 6 peer-reviewed journal articles. Her work garnered 99 citations, demonstrating significant influence in the field. The case satisfied the Dhanasar prongs by addressing a critical national health need, as over 2 million new cancer cases were expected in 2024.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Original Contributions
Government Alignment

Similar Cases

Postdoctoral Researcher

Biotechnology · Japan

WeGreened EB-2 (NIW) approved
54 days 2025-04-01
The petitioner proposes to develop advanced diagnostic and therapeutic approaches for cancer through biomarker identification and optimized combination therapies. This work focuses on enhancing early detection, personalizing treatment plans, and improving survival outcomes for cancer patients within the biotech and pharmaceutical industry.

Scientist

Biotechnology · Nepal

WeGreened EB-2 (NIW) approved
Massachusetts 47 days 2025-02-06
The petitioner proposes to continue research in cancer precision medicine by leveraging omics-based data, including genomic, transcriptomic, and proteomic analyses. The work focuses on identifying clinically actionable biomarkers to develop personalized therapies and improve patient outcomes for those with cancer.

Assistant Professor

Healthcare · Lebanon

WeGreened EB-2 (NIW) approved
New York 283 days 2025-02-14
The petitioner proposes to continue his clinical research in precision oncology and immune profiling, focusing on the use of biomarkers to improve the diagnosis and treatment of complex cancers such as renal cell carcinoma and multiple myeloma. His work involves the development and validation of novel imaging and staining techniques to better understand immune microenvironments and treatment responses.

Postdoctoral Researcher

Biotechnology · China

WeGreened EB-2 (NIW) approved
California 62 days 2025-02-11
The petitioner proposes to develop sensitive assays for identifying cancer biomarkers to improve diagnostic accuracy and therapeutic strategies. Her work focuses on integrating chemistry, biology, and medical science to create low-cost, highly sensitive diagnostic tools for early cancer detection.

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

Case data sourced from publicly available petition decisions and case studies. Decision date: 2024-12-02.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 26 days
Criteria Met 3 / 3
Evidence Types 4

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,895
Success Rate 54.2%
Sustained 2,112
Dismissed 1,687

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist